Health
The US FDA has approved the Medtronic system for the treatment of heart disease
Medtronic announced that the U.S. Food and Drug Administration has approved its system to treat conditions that can cause stroke or heart failure. The PulseSelect
US healthcare spending to rise to $4.5 trillion in 2022
US healthcare spending rose 4.1 per cent in 2022 to $4.5 trillion, federal data showed. Officials said the figure indicates a return to pre-pandemic patterns
Pfizer shares fall after revising COVID expectations for 2024
Pfizer predicts sales in 2024 could be $5bn below Wall Street expectations, sending shares to a 10-year low. Revenue from Pfizer’s COVID-19 vaccine and treatment,
Eisai to launch Alzheimer’s disease drug Leqembi in Japan 20 Dec
Eisai said its Alzheimer’s disease drug Leqembi will go on sale in Japan on 20 December after being included in the national health insurance price
US Commission recommends obese children start counselling from age 6
Obese children should receive intensive counselling to promote healthy eating and exercise starting at age 6, according to a draft recommendation published by a panel
Pfizer gets approval for $43 billion deal with Seagen after donating rights to cancer drugs
Pfizer said it expects to close a $43 billion deal to buy cancer drug maker Seagen later this week and plans to create a new
Bristol Myers to pay $800 million to develop cancer drug
Bristol Myers Squibb said on Monday it will pay $800 million upfront and up to $8.4 billion to Sichuan Biokin Pharmaceutical to develop and commercialise
Weight loss from Lilly’s Zepbound reversed after stopping the treatment
Patients taking Eli Lilly’s weight-loss drug Zepbound gained significant weight almost a year after stopping treatment, according to the full results of a study. The
AstraZeneca to buy vaccine developer Icosavax for $1.1bn
Pharmaceutical company AstraZeneca said on Tuesday it had agreed to buy infectious disease vaccine developer Icosavax in a deal worth up to $1.1bn to support
Cigna abandons pursuit of Humana and plans $10 billion share buyback
US health insurer Cigna has abandoned efforts to negotiate the acquisition of rival Humana after the pair failed to agree on a price, two sources